|
1
|
Lee Y, Jeon K, Lee JT, Kim S and Kim VN:
MicroRNA maturation: Stepwise processing and subcellular
localization. EMBO J. 21:4663–4670. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S, et al: The nuclear RNase III
Drosha initiates microRNA processing. Nature. 425:415–419. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel B and Bartel DP: MicroRNAs: At the
root of plant development? Plant Physiol. 132:709–717. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khvorova A, Reynolds A and Jayasena SD:
Functional siRNAs and miRNAs exhibit strand bias. Cell.
115:209–216. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doench JG, Petersen CP and Sharp PA:
siRNAs can function as miRNAs. Genes Dev. 17:438–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang YS, Dai Y, Yu XF, Bao SY, Yin YB,
Tang M and Hu CX: Microarray analysis of microRNA expression in
hepatocellular carcinoma and non-tumorous tissues without viral
hepatitis. J Gastroenterol Hepatol. 23:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of MicroRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting IL-6-Stat3 pathway. Hepatology. 58:158–170.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao J, Liang L, Huang S, Ding J, Tan N,
Zhao Y, Yan M, Ge C, Zhang Z, Chen T, et al: MicroRNA-30d promotes
tumor invasion and metastasis by targeting Galphai2 in
hepatocellular carcinoma. Hepatology. 51:846–856. 2010.PubMed/NCBI
|
|
15
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai S, Nasser MW, Wang B, Hsu SH, Datta J,
Kutay H, Yadav A, Nuovo G, Kumar P and Ghoshal K: MicroRNA-122
inhibits tumorigenic properties of hepatocellular carcinoma cells
and sensitizes these cells to sorafenib. J Biol Chem.
284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Tan W, Neo TW, Aung MO, Wasser S,
Lim SG and Tan TM: Role of the miR-106b-25 microRNA cluster in
hepatocellular carcinoma. Cancer Sci. 100:1234–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX
and Zhong L: Decrease expression of microRNA-20a promotes cancer
cell proliferation and predicts poor survival of hepatocellular
carcinoma. J Exp Clin Canc Res. 32:212013. View Article : Google Scholar
|
|
19
|
Fukamachi H and Ito K: Growth regulation
of gastric epithelial cells by Runx3. Oncogene. 23:4330–4335. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng Z, Wei D, Wang L, Tang H, Zhang J, Le
X, Jia Z, Li Q and Xie K: RUNX3 inhibits the expression of vascular
endothelial growth factor and reduces the angiogenesis, growth, and
metastasis of human gastric cancer. Clin Cancer Res. 12:6386–6394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsu PI, Hsieh HL, Lee J, Lin LF, Chen HC,
Lu PJ and Hsiao M: Loss of RUNX3 expression correlates with
differentiation, nodal metastasis, and poor prognosis of gastric
cancer. Ann Surg Oncol. 16:1686–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chuang LS and Ito Y: RUNX3 is
multifunctional in carcinogenesis of multiple solid tumors.
Oncogene. 29:2605–2615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Subramaniam MM, Chan JY, Soong R, Ito K,
Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, et
al: RUNX3 inactivation in colorectal polyps arising through
different pathways of colonic carcinogenesis. Am J Gastroenterol.
104:426–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li QL, Ito K, Sakakura C, Fukamachi H,
Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al: Causal
relationship between the loss of RUNX3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wada M, Yazumi S, Takaishi S, Hasegawa K,
Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, et al:
Frequent loss of RUNX3 gene expression in human bile duct and
pancreatic cancer cell lines. Oncogene. 23:2401–2407. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yanada M, Yaoi T, Shimada J, Sakakura C,
Nishimura M, Ito K, Terauchi K, Nishiyama K, Itoh K and Fushiki S:
Frequent hemizygous deletion at 1p36 and hypermethylation
downregulate RUNX3 expression in human lung cancer cell lines.
Oncol Rep. 14:817–822. 2005.PubMed/NCBI
|
|
27
|
Nishio M, Sakakura C, Nagata T, Komiyama
S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A, et
al: RUNX3 promoter methylation in colorectal cancer: Its
relationship with microsatellite instability and its suitability as
a novel serum tumor marker. Anticancer Res. 30:2673–2682.
2010.PubMed/NCBI
|
|
28
|
Zheng Y, Zhang Y, Huang X and Chen L:
Analysis of the RUNX3 gene methylation in serum DNA from esophagus
squamous cell carcinoma, gastric and colorectal adenocarcinoma
patients. Hepatogastroenterology. 58:2007–2011. 2011.PubMed/NCBI
|
|
29
|
Kitago M, Martinez SR, Nakamura T, Sim MS
and Hoon DS: Regulation of RUNX3 tumor suppressor gene expression
in cutaneous melanoma. Clin Cancer Res. 15:2988–2994. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, et
al: Singapore Gastric Cancer Consortium: MicroRNA-130b regulates
the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer.
46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Z, Chen L, Zhang X, Xu X, Xing H,
Zhang Y, Li W, Yu H, Zeng J and Jia J: RUNX3 regulates vimentin
expression via miR-30a during epithelial-mesenchymal transition in
gastric cancer cells. J Cell Mol Med. 18:610–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakanishi Y, Shiraha H, Nishina S, Tanaka
S, Matsubara M, Horiguchi S, Iwamuro M, Takaoka N, Uemura M, Kuwaki
K, et al: Loss of runt-related transcription factor 3 expression
leads hepatocellular carcinoma cells to escape apoptosis. BMC
Cancer. 11:32011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Connolly E, Melegari M, Landgraf P,
Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M,
Tuschl T and Rogler CE: Elevated expression of the miR-17-92
polycistron and miR-21 in hepadnavirus-associated hepatocellular
carcinoma contributes to the malignant phenotype. Am J Pathol.
173:856–864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JH, Pyon JK, Kim DW, Lee SH, Nam HS,
Kang SG, Kim CH, Lee YJ, Chun JS and Cho MK: Expression of RUNX3 in
skin cancers. Clin Exp Dermatol. 36:769–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee CWL, Chuang LSH, Kimura S, Lai SK, Ong
CW, Yan B, Salto-Tellez M, Choolani M and Ito Y: RUNX3 functions as
an oncogene in ovarian cancer. Gynecol Oncol. 122:410–417. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin FC, Liu YP, Lai CH, Shan YS, Cheng HC,
Hsu PI, Lee CH, Lee YC, Wang HY, Wang CH, et al: RUNX3-mediated
transcriptional inhibition of Akt suppresses tumorigenesis of human
gastric cancer cells. Oncogene. 31:4302–4316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Voon DC, Wang H, Koo JK, Nguyen TA, Hor
YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP, et al: Runx3
protects gastric epithelial cells against epithelial-mesenchymal
transition-induced cellular plasticity and tumorigenicity. Stem
Cells. 30:2088–2099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tanaka S, Shiraha H, Nakanishi Y, Nishina
S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J,
Kuwaki K, et al: Runt-related transcription factor 3 reverses
epithelial-mesenchymal transition in hepatocellular carcinoma. Int
J Cancer. 131:2537–2546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W, et al: MiR-20a induces cell
radioresistance by activating the PTEN/PI3K/Akt signaling pathway
in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
